Newsroom | 10978 results

Sorted by: Latest
Surgery
-

First Clinical Study of SeptAlign™ Implant Demonstrates Safety and Efficacy in Treating Nasal Septal Deviation While Preserving Cartilage

SOUTH SAN FRANCISCO, Calif.--(BUSINESS WIRE)--Spirair, Inc., an early-stage company developing minimally invasive solutions to help ENTs improve patient care, today announced the publication of the first clinical study evaluating its SeptAlign™ implant. The positive 12-month outcomes demonstrate the safety and efficacy of this novel bioabsorbable device, which offers a cartilage-sparing approach to traditional septoplasty for the treatment of nasal septal deviation (NSD). NSD is a leading cause...
-

As mais recentes tecnologias cirúrgicas inovadoras da Alcon, o UNITY® VCS e o UNITY® CS, são aprovadas no Brasil

SÃO PAULO--(BUSINESS WIRE)--A Alcon, líder global em cuidados com a visão dedicada a ajudar as pessoas a verem de forma brilhante, anuncia que o equipamento para cirurgias de retina e vítreo e de catarata (VCS/CS) UNITY®, bem como o equipamento de catarata (CS) UNITY®, receberam a aprovação da Agência Nacional de Vigilância Sanitária (ANVISA). Trata-se de uma inovação sem precedentes do aguardado portfólio UNITY® da Alcon a serem introduzidas no Brasil. "Estamos extremamente entusiasmados em ap...
-

bioAffinity Technologies President and CEO Maria Zannes Appointed to American Lung Association in Texas’ Leadership Board

SAN ANTONIO--(BUSINESS WIRE)--bioAffinity CEO Maria Zannes joins the American Lung Association in Texas' Leadership Board of to advance prevention and treatment of lung disease....
-

Instrumentum Accelerates Growth With Multiple Acquisitions, Increasing National Presence

BOCA RATON, Fla.--(BUSINESS WIRE)--Instrumentum, the emerging leader in surgical instrument sterilization services, announced the acquisitions of Sterile Processing Express (SPDx) based in Phoenix, Arizona, and Sterile Processing Services of America (SPSA), with facilities in Long Beach and Modesto, California. These acquisitions expand Instrumentum’s footprint to five facilities across four states, strengthening its capability to meet rising surgical instrument sterilization demands for health...
-

Global Healthy Living Foundation Showcases Patient-Centered Digital Innovations for Rheumatic and Musculoskeletal Diseases at European Arthritis Conference

UPPER NYACK, N.Y.--(BUSINESS WIRE)--GHLF presents innovative digital solutions designed to address suboptimal treatment and enhance disease management...
-

Anaconda Biomed Appoints Dr. Charles Carignan as New Chairman of the Board of Directors

BARCELONA, Spain & MARIN, Calif.--(BUSINESS WIRE)--Anaconda Biomed S.L., a medical technology company developing next-generation thrombectomy systems for the treatment of ischemic stroke, announced today the appointment of long-time medtech executive Charles (Chuck) Carignan, M.D., as chairman of the board. Dr. Carignan brings extensive clinical, product development, commercialization, and leadership expertise to the role. He has served on committees of the U.S. Food and Drug Administration, Ce...
-

ヒストソニックスとケンブリッジ大学、李嘉誠基金会の寄付により導入された欧州初のエジソン™・ヒストトリプシー・システムを発表

ミネアポリス--(BUSINESS WIRE)--（ビジネスワイヤ） -- ヒストソニックスは、組織を非侵襲的に破壊する超音波治療法「エジソン®・ヒストトリプシー・システム」の製造で知られていますが、ケンブリッジ大学病院財団信託のアデンブルックズ病院が、英国および欧州大陸で初めて、英国国民保健サービス（NHS）および民間の患者にヒストトリプシーを提供する施設となると発表しました。これは、李嘉誠基金会（LKSF）の寛大な寄付と、英国医薬品・医療製品規制庁（MHRA）が限定的な早期市場でのヒストトリプシーの使用を2025年4月に承認したことで可能となりました。 このマイルストーンは、ヒストソニックスの英国および欧州市場への正式参入を意味します。ヒストソニックスは2024年に英国の革新的医療機器アクセス経路（IDAP）のパイロットプログラムにおける選定された場所を獲得し、このプログラムを通じて英国保健・社会福祉省（DHSC）、MHRA、英国国立健康研究所（NIHR）、イングランド地域管轄の国民健康・医療制度（NHSE）、英国国立保健医療技術評価機構（NICE） と連携して患者へのアクセスを...
-

Resumen: HistoSonics y la Universidad de Cambridge presentan el primer sistema de histotricia Edison™ de Europa gracias a una donación de la Li Ka Shing Foundation

MINNEÁPOLIS--(BUSINESS WIRE)--HistoSonics, fabricante del sistema de histotricia Edison® y de novedosas plataformas de terapia de histotricia, ha anunciado hoy que el hospital Addenbrookes de la Cambridge University Hospital Foundation and Trust será el primer centro del Reino Unido y del continente europeo en ofrecer histotricia tanto a pacientes del NHS como a pacientes del sistema privado. Esto ha sido posible gracias a una generosa donación de la Li Ka Shing Foundation (LKSF), así como al a...
-

Riassunto: HistoSonics e Cambridge University presentano il primo Edison™ Histotripsy System reso possibile dalla Li Ka Shing Foundation Gift in Europa

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, il produttore dell'Edison® Histotripsy System e di nuove piattaforme terapeutiche per l'istotripsia, ha annunciato oggi che l'Addenbrookes Hospital della Cambridge University Hospital Foundation and Trust sarà la prima struttura ospedaliera nel Regno Unito e in Europa a offrire l'istotripsia a pazienti sia nel sistema sanitario nazionale britannico (NHS) che privati. L'iniziativa è stata resa possibile grazie a una generosa donazione da parte della Li...
-

HistoSonics und die Universität Cambridge stellen Europas erstes Edison™-Histotripsie-System vor, das durch eine Spende der Li Ka Shing Foundation finanziert wurde

MINNEAPOLIS--(BUSINESS WIRE)--HistoSonics, Hersteller des Edison® Histotripsy-Systems und neuartiger Histotripsy-Therapieplattformen, gab heute bekannt, dass das Addenbrookes Hospital der Cambridge University Hospital Foundation and Trust als erste Einrichtung im Vereinigten Königreich und auf dem europäischen Kontinent Histotripsy sowohl für NHS- als auch für Privatpatienten anbieten wird. Ermöglicht wurde dies durch eine großzügige Spende der Li Ka Shing Foundation (LKSF) sowie die beschleuni...